Company news

Proteomics International Laboratories Ltd. news in 2023

Proteomics International Laboratories Ltd.'s news releases, calls and decks from 2023, newest first.

View company

PromarkerD licence with Omics Global extended to Chile

December 19, 2023

US Medicare confirms reimbursement price for PromarkerD

November 21, 2023

Proteomics receives $1.85 million in R&D tax incentive

November 8, 2023

September 2023 Quarterly Activities Report and Appendix 4C

October 25, 2023

Reinstatement to Quotation

September 28, 2023

PromarkerD US reimbursement price & Aus regulatory decision

September 28, 2023

Suspension from Quotation

September 18, 2023

New oesophageal cancer test presented at global conference

September 7, 2023

OxiDx platform technology secures patent in Japan

September 3, 2023

June 2023 Quarterly Activities Report and Appendix 4C

July 23, 2023

Sonic Healthcare USA signs licence for PromarkerD in the US

May 10, 2023

World Endometriosis Congress - New diagnostic test showcased

May 4, 2023

Canagliflozin lowers PromarkerD DKD risk prediction scores

May 2, 2023

March 2023 Quarterly Activities Report and Appendix 4C

April 26, 2023

Proteomics renews ISO 13485 and ISO 17025 accreditations

April 16, 2023

New endometriosis test presented at international conference

March 24, 2023

PromarkerD application for Australian MBS to be resubmitted

March 15, 2023

Distribution agreement for PromarkerD in Britain extended

February 14, 2023

December 2022 Quarterly Activities Report and Appendix 4C

January 30, 2023

Letter of intent with Sonic Healthcare USA extended

January 30, 2023

CPT PLA reimbursement code approved in US for PromarkerD

January 2, 2023

Decks in 2023